U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Dextrose 50% Injection
Status: Currently in Shortage
»Date first posted: 01/13/2022
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Expand all

Amphastar Pharmaceuticals, Inc./IMS (Reverified 08/12/2022)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 g/50 mL (0.5 g/mL), syringe, 10 per carton (NDC 76329-3302-1) (old NDC 76329-3301-1) Backorder due to increase in demand Demand increase for the drug

Hospira, Inc. (Revised 09/12/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 g/50 mL (0.5 g/mL), plastic syringe, 10 per bundle (NDC 0409-7517-16) Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: December 2022 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Pfizer Customer Letter dated March 4, 2022.

Other
25 g/50 mL (0.5 g/mL), glass syringe, 10 per bundle (NDC 0409-4902-34) Next Delivery: October 2022; Estimated Recovery: December 2022 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Pfizer Customer Letter dated March 4, 2022.

Other
25 g/50 mL (0.5 g/mL), single dose vial, 25 per tray (NDC 0409-6648-02) Next Delivery: September 2022; Estimated Recovery: July 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
Back to Top